Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies

Status: Recruiting
Location: See location...
Intervention Type: Genetic
Study Type: Observational
SUMMARY

Brain somatic mutations in genes belonging to the mTOR signaling pathway are a frequent cause of cortical malformations, including focal cortical dysplasia or hemimegalencephaly. The present study aims to search for brain somatic mutations in paired blood-brain samples and perform functional validation in children with drug-resistant focal epilepsy

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3 months
Maximum Age: 25
Healthy Volunteers: f
View:

• Children with focal drug-resistant epilepsy including Focal Cortical Dysplasia, Hemimegalencephaly, Tuberous Sclerosis, Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE), Hypothalamic Hamartomas, Sturge-Weber syndrome, Rasmussen encephalitis, gliomas)

• Their parents who have signed informed consent 1) for their child's participation (for parents) and 2) for themselves

• Social security coverage or foreign regime recognized in France

Locations
Other Locations
France
Fondation Ophtalmologique Adolphe de Rothschld
RECRUITING
Paris
Contact Information
Primary
Amelie YAVCHITZ, MD
ayavchitz@for.paris
+33 1 48 03 64 54
Backup
Mathilde Chipaux, MD
mchipaux@for.paris
01 48 03 69 43
Time Frame
Start Date: 2015-12-12
Estimated Completion Date: 2030-12
Participants
Target number of participants: 450
Treatments
Children undergoing epilepsy surgery at the Rothschild Foundation, Paris.
Sequencing of paired blood-brain DNA samples
Sponsors
Leads: Fondation Ophtalmologique Adolphe de Rothschild

This content was sourced from clinicaltrials.gov